About the Journal
Translational Andrology and Urology
Aims and Scope
Translational Andrology and Urology (TAU; Transl Androl Urol; Print ISSN 2223-4683; Online ISSN 2223-4691; http://tau.amegroups.com) is an open access, peer-reviewed and monthly journal that covers various aspects in diseases of male and female urinary tract including kidneys, ureters, bladder and urethra and the male reproductive organs like penis, testes, scrotum, prostate, etc. TAU is indexed in PubMed/PubMed Central (PMC), Scopus and Web of Science [Science Citation Index Expanded (SCIE)] and its latest impact factor for TAU is 1.9. Meanwhile, TAU is endorsed by the Genitourinary Medical Association of China International Exchange and Promotive Association for Medical and Health Care (GUA-CPAM).
TAU is indexed in PubMed/PubMed Central, Scopus and Web of Science [Science Citation Index Expanded (SCIE)] and the SCIE impact factor 2023 for TAU is 1.9. TAU is endorsed by the Genitourinary Medical Association of China International Exchange and Promotive Association for Medical and Health Care (GUA-CPAM).
The entire submission and review process are managed through OJS system, an electronic system, which provides an efficient way and ensures a rapid turnaround of papers submitted for publication. Articles will be published both in print and online. See more at Information for Authors.
Indexing
Translational Andrology and Urology is indexed and covered by
- Web of Science [Science Citation Index Expanded (SCIE)]
- PubMed
- PubMed Central (PMC)
- Scopus
- Google Scholar
- Medscape
- MDlinx
Information for Authors
TAU is a member of Committee on Publication Ethics (COPE) and it follows the Committee on Publication Ethics (COPE)'s guidelines and the ICMJE recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journal.
Manuscripts submitted must be the original work of the author(s) and must not be published previously or under consideration for publication elsewhere.
Manuscripts Turnaround Time
- In-house review: 1-3 weeks
- External peer review: 1-3 months
- Publication Ahead of Print: within 1 month after being accepted
- Formal publication: within 1-3 months after being accepted. Original Articles are listed as priority.
TAU is the Official Publication of:
- Society for Translational Medicine (STM), Hong Kong
Publication Schedule
Published quarterly from Mar. 2012 to Dec. 2014 and bimonthly from Jan. 2015 to Dec. 2020, TAU now follows a monthly publication model.
Open Access Statement
This journal is a peer reviewed, open access journal. All content of the journal is published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). All articles published open access will be immediately and permanently free for all to read, download, copy and distribute as defined by the applied license.
Free access and usage
Permitted third party reuse is defined by the CC BY-NC-ND 4.0 license. This license allows users to copy and distribute the article, provided:
- this is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way.
- the user gives appropriate credit (with a link to the formal publication through the relevant DOI) and provides a link to the license but not in an any way implying that the licensor is endorsing the user or the use of the work.
- no derivatives including remix, transform, or build upon the material was allowed for distribution.
The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright
For open access publishing, this journal uses an exclusive licensing agreement. Authors will transfer copyright to AME Publishing Company, but will have the right to share their article in the same way permitted to third parties under the relevant user license, as well as certain scholarly usage rights.
For any inquiry/special circumstance on the copyright, commercial usage or adaptation of TAU articles, please contact: permissions@amegroups.com
For reprint order, please contact: sales@amegroups.com
Support for Authors to Comply with Funding Body Mandates
We work with authors of research articles supported by funding bodies with open access mandates to ensure that authors can meet their funders’ requirements for public access to research results.
In addition, we offer further support for authors who are required to comply with funding body mandates, including but not limited to:
- All articles published open access will be immediately and permanently free for everyone to read, download, copy and distribute. If a specific open access license is needed, please contact the editorial office for confirmation before submission. Example of statements in a published article: https://jgo.amegroups.org/article/view/76355/html.
- No copyright is claimed for any work of the U.S. government. Example of statements in published articles: https://actr.amegroups.org/article/view/8875; https://med.amegroups.org/article/view/8358/html.
Editorial Office
Email: tau@amepc.org
Publisher Information
TAU is published by AME Publishing Company.
Addresses:
Hong Kong branch office: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.
Singapore branch office: Pico Creative Centre, 20 Kallang Ave #03-08, 339411 Singapore, Singapore.
Updated on July 19, 2024